Metal and metalloid-containing compounds exhibit a wide range of
biological and biocidal activities, some of which have been
employed in medicines and drugs. Polymers containing metal or
metalloid functions become a natural extension of this effort; just
as organic compound drugs have been chemically bound to polymers or
physically imbibed into polymer matrices in order to provide a
variety of useful advantages, the same opportunities exist for
using metal and metalloid species. This volume will cover important
biomedical applications of organometallic compounds, including
metal-labeled DNA on surfaces, artificial metallo-DNA, organotin
molecules as anti-cancer drugs, and much more.
* Provides useful descriptions of biomedical applications for the
reader to apply in his/her research into materials, polymers, and
medicine/drug development.
* Edited by high-quality team of macromolecular experts from around
the world
Über den Autor
Dr. Alaa Abd-El-Aziz is Professor of Chemistry and the Associate
Vice-President of Research & Graduate Studies at the University
of Winnipeg.
Dr. Charles Carraher is Professor of Chemistry at Florida
Atlantic University and Associate Director of the Florida Center
for Environmental Studies.
Dr. Charles Pittman has a B.S. in Chemical Engineering from
Lafayette College and a Ph.D. in Organic Chemistry from
Pennsylvania State University. He completed postdoctoral studies
with G. A. Olah, and served on active duty at the U.S. Army
University of Alabama. He was appointed Full Professor in 1975 and
University Research Professor in 1977. Dr. Pittman came to
Mississippi State in 1983 as Professor of Industrial Chemistry and
Catalysis. He is also Research Director of the University/Industry
Chemical Research Center.
Martin Zeldin is a Visiting Professor of Chemistry at the Hobart
and William Smith Colleges. He received his Ph.D. in inorganic
chemistry in 1968 from Pennsylvania State University.
John Sheats is the Chairperson of the Department of Chemistry
and a Professor of Chemistry at Rider University.